Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.2500
-0.0107 (-4.10%)
At close: Mar 17, 2026, 4:00 PM EDT
0.2574
+0.0074 (2.96%)
After-hours: Mar 17, 2026, 7:59 PM EDT

Plus Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.760.088.5518.1218.4
Short-Term Investments
4.363.53---
Cash & Short-Term Investments
13.113.618.5518.1218.4
Cash Growth
263.67%-57.84%-52.79%-1.52%120.47%
Other Receivables
0.320.57---
Total Trade Receivables
0.320.57---
Other Current Assets
1.731.081.283.71.32
Total Current Assets
15.175.269.8321.8219.72
Net Property, Plant & Equipment
0.330.521.111.571.82
Other Intangible Assets
0.330.470.040.090.05
Goodwill
0.370.370.370.370.37
Other Long-Term Assets
0.120.010.030.010.02
Total Assets
16.336.6311.3923.8721.98
Accounts Payable
5.9211.296.6310.134.15
Short-Term Debt
0.753.29---
Current Portion of Long-Term Debt
--3.981.611.61
Current Portion of Leases
0.060.040.120.110.11
Unearned Revenue
0.930.93---
Other Current Liabilities
4.66----
Total Current Liabilities
12.3115.5510.7311.855.87
Long-Term Debt
---3.795.01
Long-Term Leases
0.020.03--0.27
Other Long-Term Liabilities
----0
Total Long-Term Liabilities
0.020.03-3.795.28
Total Liabilities
12.3315.5810.7315.6411.15
Common Stock
0.140.01---
Treasury Stock
-0.5-0.5---
Additional Paid-in Capital
520.22485.02---
Retained Earnings
-515.87-493.48---
Shareholders' Equity
4-8.95---
Total Liabilities & Equity
16.336.6310.7315.6411.15
Total Debt
0.823.374.15.56.99
Net Cash (Debt)
12.290.244.4612.6211.41
Net Cash Growth
5043.52%-94.64%-64.66%10.60%738.75%
Net Cash Per Share
0.160.031.427.2114.15
Book Value
4-8.95000
Book Value Per Share
0.05-1.16---
Tangible Book Value
3.29-9.79-0.41-0.47-0.42
Tangible Book Value Per Share
0.04-1.27-0.13-0.27-0.52
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q